This update from Apple will improve the functionality of this app. No new features are included.

Information about the use of the reversal agent, Idarucizumab (Praxbind) for life-threatening or uncontrolled bleeding and emergency surgery.

Information about dabigatran assay.

Provides a link to our patients support website, Coagulation Conversation and our Facebook page

Added new indications; management of venous thrombosis and pulmonary embolus. Updated prescribing information. Minor modification to the guidelines for bleeding in line with recent publications.

Version for iOS 7. Revised drug interactions. Minor typos an bugs fixed.

Up to date prescribing information. Links to full prescribing information. Revised guidelines to manage bleeding. Clearer advice for each indication. iPhone 5 compatible

Changes to prescibing information for Australia in line with product information as approved by the TGA. Minor changes to New Zealand prescribing to include suggested dose reduction in some circumstances. UK dosing in line with NICE guidance including link to NICE appraisal guidance for dabigatran.

Includes international prescribing information and the ability to change the units for creatinine and patient's weight.

Easier data entry